The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia
Open accessAbstract
The laminar cortical distribution of the [125I]alpha-bungarotoxin, [3H]cytisine and [3H]epibatidine nicotinic acetylcholine receptor ligands was investigated by quantitative autoradiography in autopsy tissue from the cingulate, orbitofrontal and temporal cortices of control and schizophrenia subjects matched for age and smoking history. Different laminar binding patterns were observed for the various nicotinic ligands both in schizophrenic and control brains. [125I]alpha-Bungarotoxin binding was distributed homogeneously across all cortical layers in all three brain regions, with highest binding densities in the cingulate cortex. [3H]Cytisine and [3H]epibatidine binding varied across the cortical ribbon, with high binding in layers I, III, V and VI, within the three cortical regions. A significantly reduced [125I] alpha-bungarotoxin binding (-54%) was observed in the cingulate cortex of schizophrenia subjects, in comparison with normal individuals who smoked tobacco. In the same brain region also a significantly higher [3H]cytisine binding (48-77%) was observed in nearly all layers, except for layer I of the schizophrenia subjects, when compared to normal individuals with a history of tobacco use. No significant changes in [3H]epibatidine binding was observed within the individual cortical layers between control subjects and patients with schizophrenia, but when calculated as a whole region (i.e. measurements performed across the whole cortical ribbon), the temporal cortex showed a significant increase in [3H]epibatidine binding in schizophrenia subjects compared to control subjects. The results suggest opposite changes of the alpha4beta2 and alpha7 nicotinic receptor subtypes in the cingulate cortex of patients with schizophrenia which might reflect involvement of two different nicotinic receptor mechanisms in schizophrenia brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, anomalies in the availability or expression of specific nAChR subunits have been implicated in depression [104] and schizophrenia patients [105, 106].”
From Adolescent nicotine exposure and persistent neurocircuitry changes: unveiling lifelong psychiatric risks (2025) · cites this paper as [106]
Citations
Cites
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Progress in experimental personality research
Maher, W. B., & Maher, B. A. (1964) · Academic Press eBooks · Cited by 2,347
Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471
Prevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058
Clarke, P. B. S., Schwartz, R., Paul, S. M., Cb, P., & Pert, A. (1985) · Journal of Neuroscience · doi:10.1523/jneurosci.05-05-01307.1985 · Cited by 1,037
Physiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate Neurons
McGehee, D. S., & Role, L. W. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.002513 · Cited by 1,022
A functional neuroanatomy of hallucinations in schizophrenia
Silbersweig, D. A., Stern, E., Frith, C., Cahill, C., Holmes, A., Grootoonk, S., Seaward, J., McKenna, P., Chua, S. E., Schnorr, L., et al. (1995) · Nature · doi:10.1038/378176a0 · Cited by 906
Adler, L. E., Pachtman, E., Franks, R. D., Pecevich, M., Waldo, M. C., & Freedman, R. (1982) · PubMed · Cited by 896
Neuronal nicotinic receptors in the human brain
Paterson, D., & Nordberg, A. K. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00045-3 · Cited by 792
Self-citationInformation Processing and Attention Dysfunctions in Schizophrenia
Braff, D. L. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.233 · Cited by 738
Schizophrenia, sensory gating, and nicotinic receptors
Adler, L. E., Olincy, A., Waldo, M., Harris, J. G., Griffith, J., Stevens, K., Flach, K., Nagamoto, H., Bickford, P., Leonard, S., et al. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033320 · Cited by 690
Normalization of auditory physiology by cigarette smoking in schizophrenic patients
Adler, L. E., Hoffer, L., Wiser, A., & Freedman, R. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1856 · Cited by 679
Freedman, R., Hall, M., Adler, L. E., & Leonard, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00252-x · Cited by 678
Nicotinic systems and cognitive function
Levin, E. D. (1992) · Psychopharmacology · doi:10.1007/bf02247415 · Cited by 511
Nicotine Dependence in Schizophrenia: Clinical Phenomena and Laboratory Findings
Dalack, G. W., Healy, D. J., & Meador‐Woodruff, J. H. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1490 · Cited by 501
Nicotinic acetylcholine binding sites in Alzheimer's disease
Whitehouse, P. J., Martino, A. M., Antuono, P., Lowenstein, P. R., Coyle, J. T., Price, D. L., & Kellar, K. J. (1986) · Brain Research · doi:10.1016/0006-8993(86)90819-x · Cited by 485
INPUT DYSFUNCTION IN SCHIZOPHRENIA.
Venables, P. H. (1964) · PubMed · Cited by 473
Schizophrenia and smoking: an epidemiological survey in a state hospital
de León, J., Dadvand, M., Canuso, C. M., Odom-White, A., Stanilla, J. K., & Simpson, G. M. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.453 · Cited by 417
Human neuronal nicotinic receptors
Gotti, C., Fornasari, D., & Clementi, F. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00034-8 · Cited by 417
Effect of smoking history on [3H]nicotine binding in human postmortem brain
Breese, C. R., Marks, M. J., Logel, J., Adams, C. E., Sullivan, B., Collins, A. C., & Leonard, S. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36798-9 · Cited by 396
Bertrand, D., Galzi, J., Devillers‐Thiéry, A., Bertrand, S., & Changeux, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.6971 · Cited by 390
Abnormal Regulation of High Affinity Nicotinic Receptors in Subjects with Schizophrenia
Breese, C. R. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00121-4 · Cited by 343
Lohr, J. B., & FLYNN, K. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90024-y · Cited by 339
Guan, Z., Zhang, X., Blennow, K., & Nordberg, A. K. (1999) · Neuroreport · doi:10.1097/00001756-199906030-00028 · Cited by 286
Self-citationNicotinic Receptor Function in Schizophrenia
Leonard, S. S., Adams, C., Breese, C. R., Adler, L. E., Bickford, P. C., Byerley, W., Coon, H. H., Griffith, J. M., Miller, C., Myles‐Worsley, M., et al. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.431 · Cited by 263
Sensory gating deficits in schizophrenia: new results
Judd, L. L., McAdams, L. A., Budnick, B., & BRAFF, D. L. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.4.488 · Cited by 263
Whiting, P. J., & Lindström, J. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-09-03395.1988 · Cited by 262
Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia
COURT, J. A., Spurden, D., Lloyd, S. R., McKeith, I. G., Ballard, C. G., Cairns, N. J., Kerwin, R. W., Perry, R., & Perry, E. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731590.x · Cited by 252
Self-citationCortical Development and Thalamic Pathology in Schizophrenia
Jones, E. G. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.3.483 · Cited by 223
Kaiser, S., & Wonnacott, S. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.2.312 · Cited by 218
Gerzanich, V., Anand, R., & Lindstrom, J. M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09916-x · Cited by 218
Schizophrenia and Nicotinic Receptors
Freedman, R., Adler, L. E., Bickford, P. C., Byerley, W., Coon, H. H., Cullum, C. M., Griffith, J. M., Harris, J. G., Leonard, S. S., Miller, C. L., et al. (1994) · Harvard Review of Psychiatry · doi:10.3109/10673229409017136 · Cited by 217
Recent advances in defining the neuropathology of schizophrenia
Arnold, S. E., & Trojanowski, J. Q. (1996) · Acta Neuropathologica · doi:10.1007/s004010050512 · Cited by 208
Houghtling, R. A., Dávila‐García, M. I., & Kellar, K. J. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10246-0 · Cited by 193
Allosteric modulations of the nicotinic acetylcholine receptor
Léna, C., & Changeux, J. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90150-k · Cited by 179
Biological perspectives of schizophrenia
Venables, P. H. (1987) · Biological Psychology · doi:10.1016/0301-0511(87)90052-4 · Cited by 166
[3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study.
Perry, D. C., & Kellar, K. J. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12091-0 · Cited by 158
Presynaptic ionotropic receptors
McGehee, D. S., & Role, L. W. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80118-8 · Cited by 157
COURT, J. A., Piggott, M. A., Lloyd, S. R., Cookson, N., Ballard, C. G., McKeith, I. G., Perry, R. H., & Perry, E. K. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00071-3 · Cited by 156
Self-citationCOURT, J. A., Lloyd, S. R., Johnson, M. H., Griffiths, M., Birdsall, N. J. M., Piggott, M. A., Oakley, A. E., Ince, P. G., Perry, E. K., & Perry, R. H. (1997) · Developmental Brain Research · doi:10.1016/s0165-3806(97)00052-7 · Cited by 146
Self-citationNicotinic acetylcholine receptor subtypes in human frontal cortex: Changes in Alzheimer's disease
Sugaya, K., Giacobini, E., & Chiappinelli, V. A. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270314 · Cited by 144
Improvement in Smooth Pursuit Eye Movements after Cigarette Smoking in Schizophrenic Patients
D, A. O. M. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00095-x · Cited by 136
Court, J. A., Lloyd, S., Thomas, N., Piggott, M. A., Marshall, E. F., Morris, C. M., Lamb, H., Perry, R. H., Johnson, M., & Perry, E. K. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00088-8 · Cited by 135
Self-citationPresynaptic Nicotinic Receptors and the Modulation of Transmitter Release
Wonnacott, S., Drasdo, A. L., Sanderson, E. M., & Rowell, P. P. (2007) · Novartis Foundation symposium · doi:10.1002/9780470513965.ch6 · Cited by 128
Lang, W., & Henke, H. (1983) · Brain Research · doi:10.1016/0006-8993(83)90879-x · Cited by 124
Adler, L. E., Waldo, M. C., & Freedman, R. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90113-1 · Cited by 120
Regional neuropathology in schizophrenia: Where are we? Where are we going?
Shapiro, R. M. (1993) · Schizophrenia Research · doi:10.1016/0920-9964(93)90057-p · Cited by 117
Durany, N., Zöchling, R., Boissl, K. W., Paulus, W., Ransmayr, G. N., Tatschner, T., Danielczyk, W., Jellinger, K. A., Deckert, J., & Riederer, P. F. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01144-7 · Cited by 112
Chini, B., Raimond, E., Elgoyhen, A. B., Moralli, D., Balzaretti, M., & Heinemann, S. (1994) · Genomics · doi:10.1006/geno.1994.1075 · Cited by 99
Marutle, A., Berglund, U. W., Bogdanović, N., & Nordberg, A. K. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00558-7 · Cited by 96
Self-citationBiological perspectives of schizophrenia
Helmchen, H., & Henn, F. A. (1987) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 87
Happe, H. K., Peters, J. L., Bergman, D. A., & Murrin, L. C. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90484-7 · Cited by 82
Wevers, A., Jeske, A., Lobron, C., Birtsch, C., Heinemann, S., Maelicke, A., Schröder, R., & Schröder, H. C. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90286-0 · Cited by 72
The Neuropathology of Schizophrenia
Powers, R. E. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199907000-00001 · Cited by 71
Characterization of [3H]cytisine binding to human brain membrane preparations
Hall, M., Zerbe, L., Leonard, S., & Freedman, R. (1993) · Brain Research · doi:10.1016/0006-8993(93)90410-o · Cited by 64
Distribution of neuronal nicotinic receptor subunits in human brain
Rubboli, F., COURT, J. A., Sala, C., Morris, C. M., Perry, E. K., & Clementi, F. (1994) · Neurochemistry International · doi:10.1016/0197-0186(94)90055-8 · Cited by 62
Self-citationNicotinic Receptors, Smoking and Schizophrenia
Leonard, S. S., Gault, J., Adams, C. E., Breese, C. R., Rollins, Y. D., Adler, L. E., D, A. O. M., & Freedman, R. (1998) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-1998-00036 · Cited by 60
Cannon, T. D. (1996) · Annals of Medicine · doi:10.3109/07853899608999117 · Cited by 60
Sihver, W., Gillberg, P., & Nordberg, A. K. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00652-0 · Cited by 57
Self-citationSihver, W., Gillberg, P.-G., Svensson, A., & Nordberg, A. K. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00295-x · Cited by 53
Self-citationEffects of smoking on drug action
Miller, R. R. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977225part2749 · Cited by 52
Perry, E. K., COURT, J. A., Johnson, M., Piggott, M. A., & Perry, R. H. (1992) · Journal of Chemical Neuroanatomy · doi:10.1016/0891-0618(92)90056-v · Cited by 47
Self-citationWevers, A., Sullivan, J. P., Giordano, T., Birtsch, C., Monteggia, L. M., Nowacki, S., Arnerić, S. P., & Schröder, H. C. (1995) · Drug Development Research · doi:10.1002/ddr.430360205 · Cited by 18
Freedman, R. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00271-6 · Cited by 9
Vocal acoustic correlates of flat affect: Differences with other negative signs and with depression
Alpert, M., Welkowitz, J., Sobin, C. A., Rosen, A. D., Teti, D., & Borod, J. C. (1989) · Schizophrenia Research · doi:10.1016/0920-9964(89)90129-1 · Cited by 2
Research works printed but not linked: 1
- Freedman, 1998, Biological phenotypes in the genetics of schizophrenia, Biol. Psychiatry, 44, 939
Cited by
Sorted by citations
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Neurophysiological Endophenotypes of Schizophrenia: The Viability of Selected Candidate Measures
Turetsky, B. I., Calkins, M. E., Light, G. A., D, A. O. M., Radant, A. D., & Swerdlow, N. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl060 · Cited by 575
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R. S., Rollema, H., & Bertrand, D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 543
Hurst, R. S., Hajós, M., Raggenbass, M., Wall, T. M., Higdon, N. R., Lawson, J. A., Rutherford-Root, K. L., Berkenpas, M. B., Hoffmann, W. E., Piotrowski, D. W., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5269-04.2005 · Cited by 447
Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia
Martin, L., Kem, W., & Freedman, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1750-1 · Cited by 341
Metadata
- Authors
- Marutle, A., Zhang, X., Court, J., Piggott, M., Johnson, M., Perry, R., Perry, E., & Nordberg, A.
- Affiliations
- Karolinska Institutet (SE)
- Medical Research Council (GB)
- Corresponding author
- Nordberg, Agneta
- Venue
- Journal of Chemical Neuroanatomy
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 22
- Issue
- 1-2
- Pages
- 115-126
- ISSN
- 0891-0618 (ISSN-L)
- OpenAlex
- W2019990977
- Cited by
- 175
- References
- 66
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 4 · 2017: 8 · 2016: 4 · 2015: 11 · 2014: 10 · 2013: 12 · 2012: 10
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Journal of Chemical Neuroanatomy (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- schizophrenia, nicotinic acetylcholine receptors, alpha4beta2 nicotinic receptor, alpha7 nicotinic acetylcholine receptor, laminar distribution, cingulate cortex, orbitofrontal cortex, temporal cortex, alpha-bungarotoxin binding, epibatidine binding, smoking, cortical layers
- MeSH terms
- Acetylcholine, Aged, Binding Sites, Brain Chemistry, Bungarotoxins, Cerebral Cortex, Cystine, Female, Humans, Iodine Radioisotopes, Ligands, Male, Middle Aged, Neurons, Pyridines, Radioligand Assay, Receptors, Nicotinic, Schizophrenia, Tobacco Use Disorder, Tritium, Nicotinic Agonists, Bridged Bicyclo Compounds, Heterocyclic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
